1. Can the SUVmax-liver-based interpretation improve prognostic accuracy of interim and posttreatment 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma?. Issue 3 (4th March 2018) Authors: Zhang, Yuewei; Fan, Yang; Ying, Zhitao; Song, Yuqin; Zhu, Jun; Yang, Zhi; Wang, Xuejuan Journal: Leukemia & lymphoma Issue: Volume 59:Issue 3(2018) Page Start: 660 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chimeric antigen receptor-modified T cells directed against CD19 in patients with relapsed or refractory CD19-positive B-cell lymphomas: interim analysis of a phase 1 study. (September 2017) Authors: Ying, Zhitao; Xiang, Xiaoyu; Song, Yuqin; Ding, Ning; Lin, Yufu; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Liu, Yanling; Yue, Yunqiang; Yu, Xueyun; Liu, Hanzhi; Duan, Panpan; Mamuti, Mierzhati; Guo, Xiaokai Journal: Lancet oncology Issue: Volume 18(2017)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluating early interim fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with the SUVmax-liver-based interpretation for predicting the outcome in diffuse large B-cell lymphoma. Issue 9 (2nd September 2017) Authors: Fan, Yang; Zhang, Yuewei; Yang, Zhi; Ying, Zhitao; Zhou, Nina; Liu, Chen; Song, Yuqin; Zhu, Jun; Wang, Xuejuan Journal: Leukemia & lymphoma Issue: Volume 58:Issue 9(2017) Page Start: 2065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades. (12th April 2020) Authors: Liu, Weiping; Ji, Xinqiang; Song, Yuqin; Wang, Xiaopei; Zheng, Wen; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Ping, Lingyan; Ying, Zhitao; Zhang, Chen; Deng, Lijuan; Wu, Meng; Feng, Feier; Leng, Xin; Sun, Yingli; Du, Tingting; Zhu, Jun Journal: Cancer medicine Issue: Volume 9:Number 11(2020) Page Start: 3765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma. (February 2020) Authors: Batlevi, Connie L.; Sha, Fushen; Alperovich, Anna; Ni, Ai; Smith, Katy; Ying, Zhitao; Gerecitano, John F.; Hamlin, Paul A.; Horwitz, Steve M.; Joffe, Erel; Kumar, Anita; Matasar, Matthew J.; Moskowitz, Alison J.; Moskowitz, Craig H.; Noy, Ariela; Owens, Colette; Palomba, Lia M.; Straus, David; vo... Journal: European journal of cancer Issue: Volume 126(2020) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China. (31st December 2020) Authors: Ying, Zhitao; Yang, Haiyan; Guo, Ye; Li, Wenyu; Zou, Dehui; Zhou, Daobin; Wang, Zhao; Zhang, Mingzhi; Wu, Jianqiu; Liu, Hui; Zhang, Pian; Yang, Su; Zhou, Zisong; Zheng, Hongxia; Song, Yuqin; Zhu, Jun Journal: Cancer medicine Issue: Volume 10:Number 3(2021) Page Start: 999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Successful treatment of a case with synchronous follicular lymphoma and gastric adenocarcinoma with CD19 CAR T cells and literature review. (18th April 2022) Authors: Liu, Jiaxin; Cao, Fang; Li, Zhemin; Gao, Hongye; Zhang, Chen; Du, Tingting; Li, Ziyu; Song, Yuqin; Zhu, Jun; Ying, Zhitao Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 47:Number 9(2022) Page Start: 1466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The mTOR kinase inhibitor everolimus synergistically enhances the anti‐tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS‐123 on Mantle cell lymphoma. Issue 1 (16th October 2017) Authors: Li, Jiao; Wang, Xiaogan; Xie, Yan; Ying, Zhitao; Liu, Weiping; Ping, Lingyan; Zhang, Chen; Pan, Zhengying; Ding, Ning; Song, Yuqin; Zhu, Jun Journal: International journal of cancer Issue: Volume 142:Issue 1(2018) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma. Issue 12 (14th October 2020) Authors: Soumerai, Jacob D.; Ni, Andy; Alperovich, Anna; Batlevi, Connie; Bantilan, Kurt S.; Fischer, Thais; Copeland, Amanda R.; Smith, Katy; Ying, Zhitao; Younes, Anas; Zelenetz, Andrew D. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 12(2020) Page Start: 2939 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗